Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 1,866,000 | 1,848,000 | 1,874,000 | 1,975,000 | 1,925,000 |
| Cost of Goods | 631,000 | 660,000 | 680,000 | 688,000 | 631,000 |
| Gross Profit | 1,235,000 | 1,188,000 | 1,194,000 | 1,287,000 | 1,294,000 |
| Operating Expenses | 1,039,000 | 1,017,000 | 1,020,000 | 1,050,000 | 972,000 |
| Operating Income | 196,000 | 171,000 | 174,000 | 237,000 | 322,000 |
| Interest Expense | 69,000 | 71,000 | 62,000 | 73,000 | 75,000 |
| Other Income | -4,000 | 0 | -1,000 | -6,000 | 26,000 |
| Pre-tax Income | 123,000 | 100,000 | 111,000 | 158,000 | 273,000 |
| Income Tax | 10,000 | -7,000 | -31,000 | 12,000 | 227,000 |
| Net Income Continuous | 113,000 | 107,000 | 142,000 | 146,000 | 46,000 |
| Net Income | $113,000 | $107,000 | $142,000 | $146,000 | $46,000 |
| EPS Basic Total Ops | 0.08 | 0.07 | 0.09 | 0.10 | 0.03 |
| EPS Basic Continuous Ops | 0.08 | 0.07 | 0.09 | 0.10 | 0.03 |
| EPS Diluted Total Ops | 0.08 | 0.07 | 0.09 | 0.10 | 0.03 |
| EPS Diluted Continuous Ops | 0.08 | 0.07 | 0.09 | 0.10 | 0.03 |
| EBITDA(a) | $196,000 | $171,000 | $174,000 | $237,000 | $322,000 |